Combined-Modality Therapy for Early-Stage Diffuse Large B-Cell Lymphoma: Knowing When to Quit.
Harvard Medical School, Brigham and Women's Hospital, Boston, MA dlongo@nejm.org.
Dan L
DL
Longo
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000401:mortality* / Q000532:radiotherapy*; D008297:Male; D018714:Radiotherapy, Adjuvant